Abstract
Chitosan based novel occlusive bioadhesive system for prophylaxis and/or treatment of oral mucositis based on chitosan, suitable surfactants (Cetyl trimethylammonium bromide and Polyquaternium-1 (Polyquad®)) and Propolis ethanolic extract were developed and evaluated in this investigation. The positive synergy was observed combined the antifungal and antioxidant capacity of synthetic and natural biomaterials into functional biocompatible gel. The in vitro antioxidant capacity (free radical scavenging by ORAC and intrinsic reducing capacity by Folin-Ciocalteu Method) was quantified and the influence of antioxidant capacity of Propolis extract on the rate of release of nystatin, from chitosan based material was investigated. These copolymer systems are able to release the drug over several weeks and therefore may be useful as a drug carrier in the treatment of oral mucosatis.
Keywords: Antiooxidants, chitosan, hydrogels, oral mucosatis, free radicals, functional materials
Current Nanoscience
Title:Alternative Chitosan Based Drug Delivery System to Fight Oral Mucositis: Synergy of Conventional and Bioactives Towards the Optimal Solution
Volume: 8 Issue: 4
Author(s): V. Tamara Perchyonok, Shengmiao Zhang and Theunis Oberholzer
Affiliation:
Keywords: Antiooxidants, chitosan, hydrogels, oral mucosatis, free radicals, functional materials
Abstract: Chitosan based novel occlusive bioadhesive system for prophylaxis and/or treatment of oral mucositis based on chitosan, suitable surfactants (Cetyl trimethylammonium bromide and Polyquaternium-1 (Polyquad®)) and Propolis ethanolic extract were developed and evaluated in this investigation. The positive synergy was observed combined the antifungal and antioxidant capacity of synthetic and natural biomaterials into functional biocompatible gel. The in vitro antioxidant capacity (free radical scavenging by ORAC and intrinsic reducing capacity by Folin-Ciocalteu Method) was quantified and the influence of antioxidant capacity of Propolis extract on the rate of release of nystatin, from chitosan based material was investigated. These copolymer systems are able to release the drug over several weeks and therefore may be useful as a drug carrier in the treatment of oral mucosatis.
Export Options
About this article
Cite this article as:
Tamara Perchyonok V., Zhang Shengmiao and Oberholzer Theunis, Alternative Chitosan Based Drug Delivery System to Fight Oral Mucositis: Synergy of Conventional and Bioactives Towards the Optimal Solution, Current Nanoscience 2012; 8 (4) . https://dx.doi.org/10.2174/157341312801784320
DOI https://dx.doi.org/10.2174/157341312801784320 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phytoestrogen Genistein and Its Pharmacological Interactions with Synthetic Endocrine-Active Compounds
Current Pharmaceutical Design Dendrimers: A Class of Polymers in the Nanotechnology for the Delivery of Active Pharmaceuticals
Current Pharmaceutical Design Probiotics in Female Reproductive Health: Paradigms, Prospects and Challenges
Current Women`s Health Reviews Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches
Current Pediatric Reviews Nanoemulsion Encapsulation and In Vitro SLN Models of Delivery for Cytotoxic Methotrexate
Current Drug Discovery Technologies The Complexity of Aging: Cancer Risk Among Elderly People and Infectious Risk Among Those with Cancer
Anti-Cancer Agents in Medicinal Chemistry Exploring Modifications in Fetal Telomere Programming in Mothers Exposed to Multiple Risk Factors
Current Women`s Health Reviews The Faulty Perinatal Hormonal Imprinting as Functional Teratogen
Current Pediatric Reviews Delivery of Therapeutic Proteins: Challenges and Strategies
Current Drug Targets MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Cardiac Disease
Recent Patents on Biomarkers The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Current Clinical Pharmacology Separation of Bioactive Peptides by Membrane Processes: Technologies and Devices
Recent Patents on Biotechnology The Woman’s Heart: Insights into New Potential Targeted Therapy
Current Medicinal Chemistry The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis
Current Signal Transduction Therapy Cytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy
Mini-Reviews in Medicinal Chemistry NF-κB in Anti-Inflammatory Activity of Probiotics: An Update
Current Immunology Reviews (Discontinued) Mucosal Vaccines: Where Do We Stand?
Current Topics in Medicinal Chemistry Medicinal Importance, Pharmacological Activities and Analytical Aspects of Canadine in Medicine: An Important Phytochemical of <i>Hydrastis canadensis</i>
Current Chinese Chemistry Antiviral Treatment of Cytomegalovirus Infection
Infectious Disorders - Drug Targets Risk of Cervical Cancer After HPV Vaccination
Current Pharmaceutical Design